GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,195 | +63.7% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $730 | +2.8% | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $710 | -3.5% | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $736 | +257.3% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $206 | -22.3% | 50 | -9.1% | 0.00% | – |
| Q4 2019 | $265 | -20.4% | 55 | 0.0% | 0.00% | – |
| Q3 2019 | $333 | -6.7% | 55 | 0.0% | 0.00% | – |
| Q2 2019 | $357 | -97.2% | 55 | -96.9% | 0.00% | -100.0% |
| Q1 2019 | $12,691 | +45.7% | 1,790 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $8,709 | -33.9% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,171 | +15.2% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,433 | +17.3% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,748 | +30.4% | 1,792 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,473 | +1261.2% | 1,792 | +3043.9% | 0.00% | – |
| Q3 2017 | $549 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |